News | Radiation Dose Management | August 12, 2016

Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program

Grants help providers establish and expand initiatives to improve patient care and safety in diagnostic imaging

AHRA, Toshiba, ninth annual Putting Patients First grant program, patient care and safety, diagnostic imaging

August 12, 2016 — The Association for Medical Imaging Management (AHRA) and Toshiba America Medical Systems Inc. announced the ninth year of its Putting Patients First grant program. Putting Patients First grants enable healthcare facilities to fund programs, training or seminars aimed at improving patient care and safety and customizing treatment in computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, X-ray and vascular imaging. The grants are funded by an unrestricted educational grant from Toshiba.

The AHRA & Toshiba Putting Patients First program provides six grants of up to $7,500 each to hospitals and imaging centers, and an additional grant of up to $20,000 to an Integrated Delivery Network (IDN). Three of the $7,500 grants are awarded for projects that improve pediatric imaging, while the other three are awarded for projects that improve overall patient care and safety in imaging. The grant of up to $20,000 is awarded to an IDN or hospital system for projects that improve overall patient care and safety in imaging across the IDN/hospital system. All winning facilities will then develop and share their best practices. 

“Since the program’s inception, Putting Patients First has awarded 50 grants totaling $490,000 to facilities that are making deliberate strides toward improving the patient experience in diagnostic imaging,” said Ernie Cerdena, CRA, FAHRA, president, AHRA. “Diagnostic imaging plays a critical role in the ways providers can improve patient safety, and we are proud to partner with healthcare facilities as they endeavor to reduce radiation, offer continuing physician education and elevate the overall patient experience.”

Putting Patients First applicants are judged on their program plan and ability to share best practices. The applicants’ programs should address one or more of the following:

  • Reducing radiation and/or contrast dose;
  • Reducing the need for sedation;
  • Improving communication with patients regarding the process;
  • Improving patient comfort; and
  • Improving the overall clinical pathway.

All eligible facilities are encouraged to apply by completing an online application at either AHRA’s or Toshiba’s website. The deadline to apply is Oct. 28, 2016, and the winners, selected by the AHRA, will be announced at the 2016 Radiological Society of North America (RSNA) annual meeting Nov. 27-Dec. 2 in Chicago.

For more information: www.ahraonline.org, www.medical.toshiba.com

Related Content

Videos | Coronavirus (COVID-19) | November 20, 2020
This video shows a computed tomography (CT) scroll through showing bowel ischemia and perforation (see arrows) due to
Single-slice of the chest CT showing the abnormalities. Arrows indicate the location of the breast mass (red arrow), lymphadenopathy (blue arrow), and a lung nodule (yellow arrow). Arrows not present in experimental display. Image courtesy of Psychonomic Bulletin & Review

Single-slice of the chest CT showing the abnormalities. Arrows indicate the location of the breast mass (red arrow), lymphadenopathy (blue arrow), and a lung nodule (yellow arrow). Arrows not present in experimental display. Image courtesy of Psychonomic Bulletin & Review

Feature | Radiology Imaging | November 20, 2020
There’s a classic video demonstrating how our brains process information and allocate attention in which people bounc
1H-MR spectra of 3 consecutive patients with COVID-19. Upper row: Axial FLAIR images at the corona radiata level show representative MRS voxels (black squares) from sampled periventricular regions. Lower row: Corresponding spectrum (black) and LCModel fit (red) from each patient acquired at TE = 30 ms (upper row) and TE = 288 ms (lower row). A, A patient with COVID-19-associated multifocal necrotizing leukoencephalopathy shows diffuse patchy WM lesions with markedly increased Cho and decreased NAA, as well

1H-MR spectra of 3 consecutive patients with COVID-19. Upper row: Axial FLAIR images at the corona radiata level show representative MRS voxels (black squares) from sampled periventricular regions. Lower row: Corresponding spectrum (black) and LCModel fit (red) from each patient acquired at TE = 30 ms (upper row) and TE = 288 ms (lower row). A, A patient with COVID-19-associated multifocal necrotizing leukoencephalopathy shows diffuse patchy WM lesions with markedly increased Cho and decreased NAA, as well as elevated Lac. B, A patient with COVID-19 after recent PEA cardiac arrest with subtle FLAIR hyperintense white matter changes also shows elevated Cho/Cr and decreased NAA/Cr ratios. However, these derangements are less severe than in the patient in A. There is no clear elevation of Lac. C, A patient with COVID-19 without encephalopathy or recent severe hypoxia has normal Cho/Cr, with mildly decreased NAA/Cr and no lactate elevation. Cho, Choline; NAA, N-Acetyl-Aspartate; mI, Myo-Inositol; Lac, Lactate; Glx, Glutamate + Glutamine. Image courtesy of AJNR

News | Coronavirus (COVID-19) | November 19, 2020
November 19, 2020 — One of the first spectroscopic imaging-based studies of neurological injury in...
SyntheticMR, an innovative software solutions company for magnetic resonance imaging (MRI) announced today the company filed a 510(k) submission for its musculoskeletal solutions package, SyMRI MSK.
News | Magnetic Resonance Imaging (MRI) | November 17, 2020
November 17, 2020 — SyntheticMR, an innovative software solutions company for...